Gracell Biotechnologies Inc ADR
(GRCL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,080 | -70,892 | -32,475 | -20,424 | N/A |
| Depreciation Amortization | 8,520 | 7,041 | 3,309 | 755 | N/A |
| Other Working Capital | 2,187 | 3,963 | -1,648 | 104 | N/A |
| Other Operating Activity | 7,395 | 12,096 | 447 | -376 | 0 |
| Operating Cash Flow | $-69,978 | $-47,792 | $-30,367 | $-19,941 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8 | 2,374 | -2,229 | 14,405 | N/A |
| PPE Investments | -7,016 | -8,904 | -12,169 | -8,312 | N/A |
| Investing Cash Flow | $-7,008 | $-6,530 | $-14,398 | $6,093 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15,166 | 11,178 | 15,787 | N/A | N/A |
| Debt Repayment | N/A | N/A | -21,256 | N/A | N/A |
| Common Stock Issued | 49 | 274 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -6,584 | N/A |
| Other Financing Activity | -10,383 | 217,055 | 121,402 | 64,732 | 0 |
| Financing Cash Flow | $4,832 | $228,507 | $115,933 | $58,148 | $N/A |
| Exchange Rate Effect | 17,877 | -5,541 | -3,390 | -90 | N/A |
| Beginning Cash Position | 265,181 | 118,367 | 47,825 | 1,751 | N/A |
| End Cash Position | 210,904 | 287,011 | 115,603 | 45,961 | N/A |
| Net Cash Flow | $-54,277 | $168,644 | $67,778 | $44,210 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,978 | -47,792 | -30,367 | -19,941 | N/A |
| Capital Expenditure | -7,016 | -8,904 | -12,169 | -8,312 | N/A |
| Free Cash Flow | -76,994 | -56,696 | -42,536 | -28,253 | 0 |